Lista de obras -

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

artículo científico publicado en 2008

Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.

artículo científico publicado en 2010

Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis

artículo científico publicado en 2014

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

artículo científico publicado en 2015

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

artículo científico publicado en 2017

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study

scientific article published on 01 March 2020

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

artículo científico publicado en 2016

Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project

artículo científico publicado en 2012

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

scientific article published on 11 March 2019

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

artículo científico publicado en 2012

Cooperative epigenetic modulation by cancer amplicon genes

artículo científico publicado en 2010

Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma

artículo científico publicado en 2008

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

artículo científico publicado en 2011

Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.

artículo científico publicado en 2016

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

artículo científico publicado en 2011

Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia

artículo científico

Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma-type post-transplant lymphoproliferative disorder

scientific article published on 18 February 2020

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

artículo científico publicado en 2020

Frequent occurrence of deletions in primary mediastinal B-cell lymphoma

article

Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.

artículo científico publicado en 2016

Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact.

artículo científico publicado en 2017

High-resolution architecture and partner genes of rearrangements in lymphoma with DLBCL morphology

artículo científico

Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma

artículo científico publicado en 2019

Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.

artículo científico publicado en 2016

Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma

artículo científico publicado en 2015

Interim PET-directed therapy in limited stage Hodgkin lymphoma initially treated with ABVD

scholarly article by Diego Villa et al published 12 July 2018 in Haematologica

International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.

artículo científico publicado en 2012

Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size

artículo científico publicado en 2008

Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy

artículo científico publicado en 2010

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

scientific article published on 13 July 2009

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

artículo científico publicado en 2011

Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas

artículo científico publicado en 2016

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation

artículo científico

Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience

artículo científico publicado en 2016

Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.

artículo científico publicado en 2015

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project

artículo científico publicado en 2011

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma

artículo científico publicado en 2008

Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis

artículo científico publicado en 2005

Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

artículo científico publicado en 2017

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

artículo científico publicado en 2015

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

artículo científico publicado en 2014

Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry

scientific article published on 01 December 2019

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk model.

artículo científico publicado en 2016

Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors

artículo científico publicado en 2013

The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.

artículo científico publicado en 2012

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

artículo científico publicado en 2007

Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma

artículo científico publicado en 2010

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome

artículo científico publicado en 2011

Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphoma

scientific article published on 10 December 2019

Ventricular arrhythmias and sudden death in patients taking ibrutinib

artículo científico publicado en 2017

Lista de obras de

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.

Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Cooperative epigenetic modulation by cancer amplicon genes

Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia

Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma-type post-transplant lymphoproliferative disorder

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

Frequent occurrence of deletions in primary mediastinal B-cell lymphoma

Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.

Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact.

High-resolution architecture and partner genes of rearrangements in lymphoma with DLBCL morphology

Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma

Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.

Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma

Interim PET-directed therapy in limited stage Hodgkin lymphoma initially treated with ABVD

International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.

Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size

Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation

Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience

Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma

Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis

Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk model.

Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors

The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome

Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphoma

Ventricular arrhythmias and sudden death in patients taking ibrutinib